Sierra Oncology Inc
SRRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$62.89
14.4% upside
Current Fair Value
14.4% upsideUndervalued by 14.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-268,399,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-7.14 |
| Beta | 0.02 |
| Outstanding Shares | 13,252,605 |
Return
| Return on Equity | -39.24% |
|---|---|
| Return on Assets | -36.67% |
| Return on Invested Capital | -38.50% |
Valuation & Multiples
| P/E Ratio | -7.7 |
|---|---|
| PEG | -19.13 |
| Price to Sales | - |
| Price to Book Ratio | 2.89 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 2.61 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sierra Oncology Inc
CEO: Stephen Dilly